BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

500 related articles for article (PubMed ID: 9933451)

  • 1. The pathogenicity of islet-infiltrating lymphocytes in the non-obese diabetic (NOD) mouse.
    Ablamunits V; Elias D; Cohen IR
    Clin Exp Immunol; 1999 Feb; 115(2):260-7. PubMed ID: 9933451
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Islet-infiltrating lymphocytes from prediabetic NOD mice rapidly transfer diabetes to NOD-scid/scid mice.
    Rohane PW; Shimada A; Kim DT; Edwards CT; Charlton B; Shultz LD; Fathman CG
    Diabetes; 1995 May; 44(5):550-4. PubMed ID: 7729614
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Islet T cells secreting IFN-gamma in NOD mouse diabetes: arrest by p277 peptide treatment.
    Ablamunits V; Elias D; Reshef T; Cohen IR
    J Autoimmun; 1998 Feb; 11(1):73-81. PubMed ID: 9480725
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Local expression of transgene encoded TNF alpha in islets prevents autoimmune diabetes in nonobese diabetic (NOD) mice by preventing the development of auto-reactive islet-specific T cells.
    Grewal IS; Grewal KD; Wong FS; Picarella DE; Janeway CA; Flavell RA
    J Exp Med; 1996 Nov; 184(5):1963-74. PubMed ID: 8920883
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Temporal relationship between immune cell influx and the expression of inducible nitric oxide synthase, interleukin-4 and interferon-gamma in pancreatic islets of NOD mice following adoptive transfer of diabetic spleen cells.
    Reddy S; Karanam M; Krissansen G; Nitschke K; Neve J; Poole CA; Ross JM
    Histochem J; 2000 Apr; 32(4):195-206. PubMed ID: 10872884
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isolation of self antigen-reactive cells from inflamed islets of nonobese diabetic mice using CD4high expression as a marker.
    Lejon K; Fathman CG
    J Immunol; 1999 Nov; 163(10):5708-14. PubMed ID: 10553102
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transfer of diabetes in the NOD-scid mouse by CD4 T-cell clones. Differential requirement for CD8 T-cells.
    Peterson JD; Haskins K
    Diabetes; 1996 Mar; 45(3):328-36. PubMed ID: 8593938
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differences in adhesion markers, activation markers, and TcR in islet infiltrating vs. peripheral lymphocytes in the NOD mouse.
    Goldrath AW; Barber L; Chen KE; Alters SE
    J Autoimmun; 1995 Apr; 8(2):209-20. PubMed ID: 7612149
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of inflammatory infiltrate in activation and effector function of cloned islet reactive nonobese diabetic CD8+ T cells: involvement of a nitric oxide-dependent pathway.
    Gurlo T; Kawamura K; von Grafenstein H
    J Immunol; 1999 Dec; 163(11):5770-80. PubMed ID: 10570259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of CD8+ cells, cell degeneration, and Fas ligand in insulitis after intraperitoneal transfer of NOD splenocytes.
    Sainio-Pöllänen S; Liukas A; Pöllänen P; Simell O
    Pancreas; 1999 Apr; 18(3):282-93. PubMed ID: 10206487
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HLA-A2-matched peripheral blood mononuclear cells from type 1 diabetic patients, but not nondiabetic donors, transfer insulitis to NOD-scid/γc(null)/HLA-A2 transgenic mice concurrent with the expansion of islet-specific CD8+ T cells.
    Whitfield-Larry F; Young EF; Talmage G; Fudge E; Azam A; Patel S; Largay J; Byrd W; Buse J; Calikoglu AS; Shultz LD; Frelinger JA
    Diabetes; 2011 Jun; 60(6):1726-33. PubMed ID: 21521873
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fas and Fas ligand immunolocalization in pancreatic islets of NOD mice during spontaneous and cyclophosphamide-accelerated diabetes.
    Redd S; Ginn S; Ross JM
    Histochem J; 2002; 34(1-2):1-12. PubMed ID: 12365794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppression of diabetes mellitus in the non-obese diabetic (NOD) mouse by an autoreactive (anti-I-Ag7) islet-derived CD4+ T-cell line.
    Chosich N; Harrison LC
    Diabetologia; 1993 Aug; 36(8):716-21. PubMed ID: 8405738
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Both CD4+ and CD8+ T-cells in syngeneic islet grafts in NOD mice produce interferon-gamma during beta-cell destruction.
    Suarez-Pinzon W; Rajotte RV; Mosmann TR; Rabinovitch A
    Diabetes; 1996 Oct; 45(10):1350-7. PubMed ID: 8826970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adoptive transfer of diabetes into immunodeficient NOD-scid/scid mice. Relative contributions of CD4+ and CD8+ T-cells from diabetic versus prediabetic NOD.NON-Thy-1a donors.
    Christianson SW; Shultz LD; Leiter EH
    Diabetes; 1993 Jan; 42(1):44-55. PubMed ID: 8093606
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Major histocompatibility complex class I-restricted infiltration and destruction of pancreatic islets by NOD mouse-derived beta-cell cytotoxic CD8+ T-cell clones in vivo.
    Utsugi T; Yoon JW; Park BJ; Imamura M; Averill N; Kawazu S; Santamaria P
    Diabetes; 1996 Aug; 45(8):1121-31. PubMed ID: 8690161
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beta-cell apoptosis in an accelerated model of autoimmune diabetes.
    Augstein P; Stephens LA; Allison J; Elefanty AG; Ekberg M; Kay TW; Harrison LC
    Mol Med; 1998 Aug; 4(8):495-501. PubMed ID: 9742505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transfer of autoimmune diabetes from diabetic NOD mice to NOD athymic nude mice: the roles of T cell subsets in the pathogenesis.
    Matsumoto M; Yagi H; Kunimoto K; Kawaguchi J; Makino S; Harada M
    Cell Immunol; 1993 Apr; 148(1):189-97. PubMed ID: 8098666
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting of pancreatic islets of severe combined immunodeficient mice by passive transfer of allogeneic spleen cells from non-obese diabetic mice.
    Reddy S; Liu W; Elliott RB
    Immunol Cell Biol; 1994 Oct; 72(5):390-7. PubMed ID: 7835983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD4+CD25+ regulatory T cells control the progression from periinsulitis to destructive insulitis in murine autoimmune diabetes.
    Ott PA; Anderson MR; Tary-Lehmann M; Lehmann PV
    Cell Immunol; 2005 May; 235(1):1-11. PubMed ID: 16122720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.